A series of 15 mononuclear complexes [PdBr((i)Pr2-bimy)(L2)]PF6 (1-15) ((i)Pr2-bimy = 1,3-diisopropylbenzimidazolin-2-ylidene, L2 = aromatic 1,2-diimines, diazabutadienes, or methylene-, ethylene- and propylene-bridged di-N-heterocyclic carbenes) and two dicarbene-bridged, dinuclear complexes [Pd2Br4((i)Pr2-bimy)2(diNHC)] (16 and 17) were synthesized and characterized by multinuclear NMR spectroscopy, electrospray ionization mass spectrometry, and in some cases X-ray diffraction analysis. The influence of the 15 bidentate ligands L2 on the (13)Ccarbene signals of the (i)Pr2-bimy reporter ligand in the chelate complexes was studied, on the basis of which a facile methodology for the donor strength determination of bidentate ligands was developed.
No takes yet. Share an insight, caveat, or question.
Teng et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: